| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |